By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies this week said that the United States-Latin American Cancer Research Network (US-LACRN) will use its microarray tools and associated products for a study of breast cancer in five Latin American nations. US-LACRN is a collaboration between the US' National Cancer Institute and the ministries of health in Mexico, Brazil, Argentina, Chile, and Uruguay.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.